LANSING, Mich., July 24, 2008 (PRIME NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB) announced today the availability of a new research report on the viability of the production of commercial quantities of spider silk and on Kraig Biocraft's role relative to the development of this technology. The report, issued by Emerging Growth Research, LLP provides an overview of the company, its technologies, and a background on the markets the company seeks to address.
The author of the report, Joseph Noel, Principal Analyst at Emerging Growth Research commented, "Kraig Biocraft has assembled a team of top genetic scientists to create transgenic technologies for the production of spider silk. Science has been attempting to artificially create spider silk for many years with only very limited success. We believe the approach being pursued by Kraig, which utilizes some of the most advanced genetic techniques available today, is very sound. We will be monitoring the situation closely as we are expecting a breakthrough this Fall as the microinjection efforts heat up at the university labs associated with the company. This is truly groundbreaking genetic research potentially worth hundreds of million of dollars."
"Spider silk is an incredible material and one of the strongest and most resilient known to mankind. Pound for pound, it is significantly stronger than steel, and its ability to absorb energy before breaking is unmatched," commented Kraig Biocraft's Chief Executive Officer, Kim K. Thompson. "We believe that a significantly sized market exists for this material, and everyone associated with Kraig Biocraft Laboratories is working diligently to deliver this revolutionary fiber to the marketplace. We are excited to have this report available to the press, our investors, and to the marketplace in general, as we believe it makes a very complex technical subject easy to understand."
The report is available for free download at: http://www.kraiglabs.com/pdf/KBLBReport.pdf
And alternatively at: http://www.scribd.com/doc/4012223/KBLB-Analyst-ReportJuly-2008
Kraig Biocraft Laboratories is a technology company focused on the development of commercially significant high-performance polymers, textile fibers and diverse platform technologies. Based on proprietary genetic engineering technology, Kraig is working to develop and produce polymers and protein-based materials including spider silk for use in the multibillion-dollar technical fibers market. For more information on Kraig Biocraft Laboratories and to hear an audio interview with Kraig's CEO, please visit the Company's website at http://www.KraigLabs.com.
The Kraig Biocraft Laboratories, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4817
About Emerging Growth Research, LLP
Emerging Growth Research, LLP operates as an independent research boutique. The Kraig Biocraft Laboratories report was produced by analyst Joseph Noel. Mr. Noel has been an analyst involved in growth companies for over 20 years and has extensive additional experience within the health care, biotech and technology sectors. Please reference the appropriate disclosures outlined in the report.
Statements in this press release about the company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "anticipates," "foresees," "hopes," "develops," "researching," "research," "could," "expecting," "potentially" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's or any analyst's outlook, objectives, plans, intentions, expectations, goals or business strategy should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.